Merck, Gardasil and Safety Suit

Merck prevails in US safety litigation over Gardasil HPV vaccine
A federal judge ruled in favor of Merck in litigation accusing it of concealing the risks of Gardasil, a vaccine to prevent cervical and other cancers caused by the human papillomavirus and one of the drugmaker's best-selling products.
Federal Judge Rules in Merck’s Favor in Gardasil Safety Suit
A federal judge ruled in Merck & Co.’s favor in a safety lawsuit over its Gardasil vaccine, allowing the drugmaker to sidestep more than 200 cases claiming the company concealed safety risks.
Good Day for Gardasil as Merck Wins Safety Suit, Drops $1B for Manufacturing Push
According to Judge Kenneth Bell, there is a lack of evidence to conclude that Merck willingly misrepresented the safety of its HPV vaccine Gardasil to patients and prescribers.
Merck prevails in Gardasil safety litigation
A federal judge has ruled in favor of Merck in litigation accusing the drugmaker of concealing the risks of Gardasil, a vaccine to prevent cervical and other fatal cancers. The decision made public on Tuesday by U.
Judge: 'Evidence Is Lacking' to Impose Warning on HPV Vaccine Gardasil
U.S. District Judge Kenneth Bell, who is overseeing the Gardasil multidistrict litigation in the Western District of North Carolina, sided with Merck on its implied preemption defense, granting summary judgment to potentially hundreds of cases.
Federal judge rules in favor of drugmaker in HPV vaccine case
A federal judge granted summary judgment in favor of Merck for part of the litigation involving the HPV vaccine, Gardasil. The rest of the case is still going on.
Fierce Pharma3d
Merck defeats claims it should have added safety warnings to Gardasil's label, knocking out 200-plus lawsuits
In a decision signed Monday, North Carolina federal judge Kenneth Bell granted Merck’s motion to dismiss the claims of ...
Merck scores victory in Gardasil lawsuits as judge questions evidence
A federal judge in North Carolina on Tuesday granted an order for summary judgment in favor of Merck (NYSE:MRK) regarding ...
Gardasil maker completes $1B North Carolina expansion — more growth on the way
New facility will manufacture HPV vaccines Gardasil and Gardasil 9. Merck plans to invest $8 billion more in U.S. by 2028. A ...
Fierce Pharma4d
Merck opens $1B Gardasil manufacturing facility in North Carolina
At its sprawling complex in Durham, N.C., Merck has opened a new $1 billion, 225,000-square-foot manufacturing plant slated ...
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims On Behalf Of Investors Of Merck & Co.
Faruqi & Faruqi, LLP , a leading national securities law firm, is investigating potential claims against Merck & Co., Inc. (“Merck” or the“Company”) (NYSE: MRK) and reminds investors of the April 14, ...
Merck opens $1 billion addition in north Durham to boost production of popular vaccine
The drugmaker Merck announced it has opened a $1 billion vaccine manufacturing facility in north Durham, a ...
Union Leader4d
Merck prevails in safety litigation over Gardasil HPV vaccine
A federal judge ruled in favor of Merck in litigation accusing it of concealing the risks of Gardasil, a vaccine to prevent ...
pharmaphorum3d
MSD opens $1bn plant for HPV vaccine in the US
MSD has opened the doors of a $1 billion manufacturing facility at its site in Durham, North Carolina, that will be used to ...